Royalty Pharma PLC logo

Royalty Pharma PLC

RPRX

$57.74
+0.19%
Royalty Pharma PLC logo

Royalty Pharma PLC

Royalty Pharma PLC is a Pharmaceuticals company listed on NASDAQ NMS - GLOBAL MARKET.

Industry
Pharmaceuticals
Exchange
NASDAQ NMS - GLOBAL MARKET
Market Cap
$33.1B
P/E Ratio
40.5
Cash on Hand
$636M(positive)
Shares Outstanding
575.8M shares
Currency
USD
Visit website →

About

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$1.30$1.32
Q1 2026$1.24$1.30
Q4 2025$1.35$1.47
Q3 2025$1.06$1.17

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$34.96 – $64.38

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
2.96%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
32.1%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+10.0%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.39

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Analyst Insights

Analyst Consensus
Buy

Based on 16 analysts

Next Earnings
Nov 3, 2026
Similar Companies

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

Hite Christopher
Sep 22, 2026 • $58.51/share
Sold 96,073
Hite Christopher
Sep 22, 2026 • $58.93/share
Sold 3,927
Hite Christopher
Aug 19, 2026
Sold 16,800
Hite Christopher
Aug 18, 2026 • $59.97/share
Sold 100,000
Coyne Terrance P.
Aug 13, 2026 • $58.59/share
Sold 9,230
Coyne Terrance P.
Aug 13, 2026 • $59.14/share
Sold 1,772

Latest SEC Filings